Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-015522)

Filing Details

Accession Number:: 0001209191-17-015522
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-28 19:34:40
Reporting Period:: 2017-02-27

Filing Date:: 2017-02-28
Accepted Time:: 2017-02-28 19:34:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Versartis Inc.	VSAR	Pharmaceutical Preparations (2834)	264106690

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1587788	Jay Shepard	C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-02-27	5,166	$2.53	219,024	No	4	M	Direct
Common Stock	Disposition	2017-02-27	5,166	$24.00	213,858	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-02-27	5,166	$0.00	5,166	$2.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,828		2023-12-27	No	4	M	Direct

Footnotes

Shares sold pursuant to 10b5-1 plan.
25% of the shares subject to the option become exercisable one year from 12/10/2013; the remainder become exercisable in equal monthly installments over the following three years.